← Eichor
Study identifier: NCT06857435 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Autologous Point-of-Care Adipose Therapy: Delayed Injury/Scar

Condition: Burns · Contracture Scar · Surgical Injury  ·  Sponsor: University of Pittsburgh

PhaseNA
Planned participants40
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

The goal of this study is to explore if an adipose-based therapeutic strategy can treat contracted scars secondary to soft-tissue burn wounds in injured individuals, especially those with severe burns or soft-tissue loss. The main question it aims to answer are: \- Can autologous layered composite grafting demonstrate non-inferiority compared to full-thickness skin grafting for delayed reconstruction of post-burn or trauma scar contracture? Researchers will compare the single-stage autologous layered composite grafting method to traditional methods to see if it improves healing outcomes, minimizes scarring, and reduces infection risk. Participants will: * Receive fat grafting at time of scar revision. * Undergo simultaneous split-thickness skin grafting for full soft-tissue reconstruction.

This description comes directly from the study's public registry record.

Talk to the study team

Eleanor Shirley  ·  412-641-8676  ·  shirleye@upmc.edu

Patsy Simon  ·  412-641-8676  ·  simopa@UPMC.EDU

Always discuss trial participation with your own doctor first.

Locations (2)

Mercy HospitalPittsburgh, Pennsylvania, United StatesRecruiting
Presbyterian HospitalPittsburgh, Pennsylvania, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06857435